Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The MutS alpha (MutSα) complex is a critical heterodimeric protein assembly composed of MSH2 and MSH6 subunits, serving as a primary sensor in the eukaryotic DNA mismatch repair (MMR) pathway [1][2]. It specifically recognizes single-base mismatches and small insertion-deletion loops (IDLs) that escape DNA polymerase proofreading during replication [2][3]. Upon binding to a mismatch, the complex utilizes its ATPase activity to undergo a conformational change, facilitating the recruitment of the MutL alpha complex to initiate the excision and resynthesis of the erroneous DNA strand [1][4]. Beyond repair, MutSα plays a pivotal role in signaling apoptosis in response to certain types of DNA damage, such as those induced by alkylating agents like temozolomide [5]. Mutations in the genes encoding MSH2 or MSH6 are a hallmark of Lynch syndrome, leading to microsatellite instability (MSI) and a significantly increased risk of colorectal, endometrial, and other cancers [6]. In oncology, the status of the MutSα complex is a vital biomarker; its deficiency renders tumors resistant to some conventional chemotherapies but highly sensitive to immune checkpoint inhibitors [7]. Furthermore, recent therapeutic developments have identified synthetic lethal targets, such as WRN helicase, which can be inhibited to selectively kill cells lacking functional MutSα [8].
Recognition of DNA mismatches and DNA adducts to initiate repair or apoptosis; synthetic lethal interaction with WRN helicase inhibitors in deficient states.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA mismatch repair protein MutS alpha complex (MutSα) (MutSα).